SEPTEMBER 2024LIFE SCIENCES REVIEW 19CXO INSIGHTShe effect of new therapies on health-related quality of life (HRQoL) has become an important consideration in establishing reimbursement and market access in many countries. A patient reported outcome is any report of the status of a patient's health condition that comes directly from the patient without interpretation of the patient's response by a clinician or anyone else. 1 The objective of this brief report is to describe the ways in which PROs are used to support reimbursement and market access in major European markets as well as the US.Countries that rely on cost-effectiveness modeling to evaluate reimbursement, such as the UK, use generic PROs that do not apply to a specific disease. The EQ-5D-5L is the tool preferred by NICE, the UK reimbursement agency, to determine the decrement in HRQoL associated with different health states TBy Lothar Tremmel, Vice President, QCSR (Quantitative Clinical Sciences and Reporting), CSLTHE ROLE OF PATIENT REPORTED OUTCOMES TO SUPPORT REIMBURSEMENT AND MARKET ACCESS IN MAJOR EUROPEAN COUNTRIES AND THE USLothar Tremmel
< Page 9 | Page 11 >